An introduction to NGS technology and applications for labs.
To learn more about the benefits of an expanded CF screen, read “Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene.” by PR Sosnay, et al.
Dr. Stuart Cook explains how targeted analysis with the TruSight Cardio Sequencing Kit can uncover inherited cardiac conditions.
See vital statistics around sudden cardiac arrest, one of the leading causes of non-traumatic fatality in the US.
Learn about the MiSeqDX Cystic Fibrosis System in this quick tutorial
Learn how Dr. Stephen Kingsmore aided in decoding the genomes of children being seen at Children’s Mercy Hospital.
Learn how Dr. Kenjiro Kosaki furthers his clinical research and expands the genetic analysis services he provides with TruSight One Sequencing Panel.
Whole-genome sequencing can potentially broaden and foreshorten differential diagnosis, resulting in fewer empirical treatments and faster progression to genetic and prognostic counseling.
Trilochan Sahoo, MD discusses the benefits of the CytoSNP-850K BeadChip array.
Hear from Dr. Heidi Rehm and how she is identifying the causal variants of cardiomyopathy
Drs. Koehler and Benet-Pages are using the Infinium CytoSNP-850K BeadChip and the TruSight Cancer Panel to analyze chromosomal abnormalities.
Discover the use of arrays to investigate individuals with intellectual disability, developmental delay, autism, and congenital abnormalities.
Download the handout on the Importance of Carrier Screening
Learn how the NextSeq 550 is enhancing research in reproductive and genetic health and why it’s being rapidly adopted in genetic testing labs. Get a glimpse into the advantages of this integrated, cost-effective solution for diverse applications.
Martin Chavez, MD, a maternal-fetal medicine specialist, discusses noninvasive prenatal testing.
"Illumina is committed to supporting independent medical education for women's healthcare providers. Click above to participate in a free CME activity about ""The Role of Noninvasive Prenatal Screening in Optimizing Fetal Outcomes"". "
A poster presentation from the 2015 Annual Meeting of the Society for Maternal- Fetal Medicine.
Prenatal testing with the use of cfDNA has significantly lower false positive rates and higher positive predictive values for detection of trisomies 21 and 18 than standard screening.
Dr. Chavez discusses the benefits of NIPT for prenatal screening of fetal chromosomal aneuploidies.
Utilize this new general educational tool to help patients understand NIPT.
Know your options in prenatal testing with an educational video on NIPT.
A video for parents to be to learn more about noninvasive prenatal testing.
The couple reflects on the value of NIPT and its ability to provide couples like them with more accurate answers.
Noninvasive prenatal testing in the general obstetric population.
For tips about how to choose the best sequencer and transform your lab, download the Buyer's Guide to Next-Generation Sequencing Systems.
Preimplantation genetic diagnosis can be used where there is a risk of severe genetic disorders being inherited from parents. Join Professor Alan Handyside and Alan Thornhill as they introduce the Illumina karyomapping solution.
Get an overview of what it means to be a balanced translocation carrier and the problems with fertility that may be experienced.
Learn how karyomapping offers a rapid PGD solution for single-gene disorders.
Alan Handyside reviews the significant breakthroughs in preimplantation genetics since the first live birth following IVF with PGD.
Dr. Alan Handyside discusses how selective implantation of euploid embryos can lead to increased pregnancy rates.
Share this brochure with your patients to educate them about PGD.
Innovative BlueFuse Multi Software provides molecular cytogenetic and in vitro fertilization (IVF) data analysis in a single framework. The seamless, scalable software solution helps simplify embryo screening and streamline the clinician’s workflow.
Watch Dagan Wells discuss how PGS through NGS improves IVF success.
Hear Simon Fishel talk about screening all 24 chromosomes with PGS.
Watch Dr. Silverberg discuss the benefits of PGS and how to utilize it in a clinical setting to improve IVF outcomes.
Learn from Dr Duraiswamy how NGS technology is empowering couples to make wiser choices.
Dagan Wells discusses how NGS has led to advancements in PGS and what we can determine about the chromosomal health of embryos.
Watch Dr. Angeline Beltsos to learn more about the advantages of PGS.
Simon Fishel shares how VeriSeq is built to handle high throughput demand with speed and accuracy.
Listen as Francesco Fiorentino discusses the high-throughput, high-resolution advantages of NGS.
Learn about the 2011-2012 Society for Assisted Reproductive Technology (SART) data analysis of pregnancy outcomes in IVF cycles with and without PGS as reported to the Centers for Disease Control (CDC).
Illumina is committed to supporting independent medical education for women’s health care providers. Click above to participate in a free CME activity about “Improving Fetal Outcomes Through the Use of PGD/PGS."
Learn how the application of NGS in clinical PGS cycles allows for identification and transfer of euploid embryos resulting in ongoing pregnancies.
Learn how Illumina technologies are used for PGS, PGD, NIPT, and research on genetic conditions in our Reproductive and Genetic Health issue.
Dagan Wells describes how high-throughput, next-generation sequencing for PGS to detect aneuploid embryos is a game changer for IVF clinics and labs.
Simon Fishel describes how the highly-accurate VeriSeq PGS Kit empowers clinicians with accurate chromosomal insights into the health of the embryo to optimize IVF success.
Francesco Fiorentino shares results of a study with high levels of implantation and pregnancy rates.
Simon Fishel describes how preimplantation genetic screening (PGS) and preimplantation genetic diagnosis (PGD) enable selection of embryos free of chromosomal problems for transfer.
Listen to Francesco Fiorentino share why he feels PGS should be applied in every IVF treatment.
Tony Gordon talks about why he chooses Illumina technology for PGS, PGD, and NIPT.
Listen as Tony Gordon shares his vision for better IVF clinical outcomes using NGS.
Hear Tony Gordon discuss how the Illumina portfolio empowers reproductive health labs.
Yang et al reported a 65% increase in pregnancy at 20 weeks, with a 69.1% pregnancy rate after 24sure selection of euploid embryos (n = 55) versus 41.7% after standard morphological selection of embryos (n = 48).
Read how PGS and PGD can improve IVF outcomes through better embryo selection.
Vital statistics that can increase successful pregnancies.
Hear Dagan Wells talk about the advantages of NGS for IVF clinics.
Hear a firsthand testimonial of how Illumina PGS technology made a difference for one family.
Dr. Robert Anderson discusses pregnancy rates achieved with PGS.
Listen to Dr. Robert Anderson discuss how PGS enables better embryo selection.
Listen to Dr. Robert Anderson share the benefits of single embryo transfer enabled by PGS.
Listen to Dr. Robert Anderson share why PGS optimizes embryo selection.
Dr. Robert Anderson shares how a lab achieves a high IVF success rate with PGS.
Dr. Jamie Grifo explains how PGS can be used to deliver fast, accurate information that can guide choices and change patients’ lives and reproductive futures.
Dagan Wells discusses how NGS has led to advancements in PGS and what we can determine about the chromosomal health of embryos.
Simon Fishel, Managing Director of CARE Fertility, describes a clinical trial on embryo chromosome analysis. He discusses the ability to analyze every single chromosome in a cell that is taken from the embryo, and only transferring embryos that are chromosomally normal.
Learn how PGS and PGD solutions can produce accurate genomic information for optimized embryo selection and more informed decisions about reproductive options.
Listen as Francesco Fiorentino discusses the high-throughput, high-resolution advantages of NGS.
A brief, educational primer about next-generation sequencing for in vitro fertilization.
"RGH Counseling Guide Booklet Learn about the latest PGS and NIPT tool with this informative booklet highlighting app features and a quick start guide.<sup>┼</sup><br><br> <sup>┼</sup> This RGH Counseling Guide is intended to offer health care providers basic information on genetic counseling and is for general educational purposes only. The guide is not intended to be used to substitute for the exercise of the health care provider’s professional judgment in providing professional services."
Join Angie Beltsos, MD, as she explores the latest advancements in fertility. Topics include minimizing risk of hyperstimulation, optimizing health of the transferred embryo, and improving the odds…
Dr. Robert Anderson, Director of the Southern California Center for Reproductive Medicine and Medical Director for the Southern California Institute for Reproductive Sciences, discusses how preimplantation…
Childhood sweethearts, now husband and wife, Vy and Kyle share their personal in vitro fertilization success story. You ll hear how Illumina preimplantation genetic screening (PGS) helped them fulfill…
Dr. Leeanda Wilton of Melbourne IVF codeveloped genomic methods that were key predecessors of technologies that are now contributing to successful IVF pregnancies.
Innovative BlueFuse Multi Software
Dr. Don Leigh and his team at Genea are harnessing the speed and accuracy of the VeriSeq PGS Solution on the MiSeq System to assess the genetic viability of embryos.
New technologies and procedures help tackle infertility.
Professor Yuval Yaron discusses the implications of test failures.
Read the blog post on positive predictive value and download the publication
Data shows Illumina next-generation sequencing is the NIPT technology of choice.
View all 174 genes, related to 17 ICCs, detected by the TruSight Cardio Sequencing Kit.
Read valuable information on sudden cardiac arrest and the relation to inherited cardiac conditions.
Download this guide for healthcare professionals on NIPT and the benefits of the verifi prenatal test.
Embryologists from all over the world gathered for the Global Embryology Summit, an exclusive event featuring hands-on instructor-led workshops designed by fellow embryologists to improve best practices…
Learn how the verifi Prenatal Test uses proven NGS technology to provide accurate NIPT results.
Maternal fetal medicine specialist Dr. Tracy Prosen highlights the differences between screening and diagnostic prenatal tests.
Whole-genome noninvasive prenatal testing provides results when another test was inconclusive.
Download this guide for parents-to-be on NIPT and the benefits of the verifi prenatal test.
An overview of recent publications featuring 24sure technology from Illumina.
Dr. Ali Hellani discusses his passion to help couples undergoing IVF by providing them with reliable genetic screening technologies.
Share this brochure with your patients to educate them about PGS and how it can improve IVF success rates.
Learn more about the MiSeqDx Cystic Fibrosis System.
Noninvasive prenatal screening (NIPT) was found cost-effective as first line screening for all pregnant women.
Noninvasive prenatal testing (NIPT) helps reduce the need for invasive procedures
Know your options in prenatal testing with an educational video on NIPT.
Dagan Wells describes how high-throughput, next-generation sequencing for PGS to detect aneuploid embryos is a game changer for IVF clinics and labs.
Hear Dagan Wells talk about the advantages of NGS for IVF clinics.
Listen as Francesco Fiorentino discusses the high-throughput, high-resolution advantages of NGS.
Noninvasive prenatal testing (NIPT) helps reduce the need for invasive procedures
Visual aids for patient discussions about reproductive genetic concepts such as PGS and NIPT.
Pam and Eric share how transferring a single embryo with PGS helped them start a family while they balanced their busy lifestyles.
Learn more about the verifi Prenatal Test- a reliable, easy, fast noninvasive prenatal test
Key opinion leaders in the fields of preimplantation genetic screening (PGS) and preimplantation genetic diagnosis (PGD) discuss how partnering with Illumina has positively impacted families around the world.
Dr. Ali Hellani discusses his passion to help couples undergoing IVF by providing them with reliable genetic screening technologies.
Learn about the MiSeqDX Cystic Fibrosis System in this quick tutorial
Dr. Stuart Cook explains how targeted analysis with the TruSight Cardio Sequencing Kit can uncover inherited cardiac conditions.
Listen to Dr. Robert Anderson share the benefits of single embryo transfer enabled by PGS.
Listen to Dr. Robert Anderson discuss how PGS enables better embryo selection.
Dr. Robert Anderson discusses pregnancy rates achieved with PGS.
Vital statistics that can increase successful pregnancies.
Hear Tony Gordon discuss how the Illumina portfolio empowers reproductive health labs.
Tony Gordon talks about why he chooses Illumina technology for PGS, PGD, and NIPT.
Listen as Tony Gordon shares his vision for better IVF clinical outcomes using NGS.
Listen to Francesco Fiorentino share why he feels PGS should be applied in every IVF treatment.
Francesco Fiorentino shares results of a study with high levels of implantation and pregnancy rates.
Simon Fishel describes how preimplantation genetic screening (PGS) and preimplantation genetic diagnosis (PGD) enable selection of embryos free of chromosomal problems for transfer.
Simon Fishel shares how VeriSeq is built to handle high throughput demand with speed and accuracy.
Dagan Wells discusses how NGS has led to advancements in PGS and what we can determine about the chromosomal health of embryos.
Watch Dr. Angeline Beltsos to learn more about the advantages of PGS.
Learn from Dr Duraiswamy how NGS technology is empowering couples to make wiser choices.
Watch Dr. Silverberg discuss the benefits of PGS and how to utilize it in a clinical setting to improve IVF outcomes.
Hear Simon Fishel talk about screening all 24 chromosomes with PGS.
Watch Dagan Wells discuss how PGS through NGS improves IVF success.
Innovative BlueFuse Multi Software provides molecular cytogenetic and in vitro fertilization (IVF) data analysis in a single framework. The seamless, scalable software solution helps simplify embryo screening and streamline the clinician’s workflow.
Dr. Alan Handyside discusses how selective implantation of euploid embryos can lead to increased pregnancy rates.
Alan Handyside reviews the significant breakthroughs in preimplantation genetics since the first live birth following IVF with PGD.
Get an overview of what it means to be a balanced translocation carrier and the problems with fertility that may be experienced.
Preimplantation genetic diagnosis can be used where there is a risk of severe genetic disorders being inherited from parents. Join Professor Alan Handyside and Alan Thornhill as they introduce the Illumina karyomapping solution.
Listen to Dr. Robert Anderson share why PGS optimizes embryo selection.
Dr. Robert Anderson shares how a lab achieves a high IVF success rate with PGS.
Dr. Jamie Grifo explains how PGS can be used to deliver fast, accurate information that can guide choices and change patients’ lives and reproductive futures.
Simon Fishel, Managing Director of CARE Fertility, describes a clinical trial on embryo chromosome analysis. He discusses the ability to analyze every single chromosome in a cell that is taken from the embryo, and only transferring embryos that are chromosomally normal.
Dagan Wells discusses how NGS has led to advancements in PGS and what we can determine about the chromosomal health of embryos.
A video for parents to be to learn more about noninvasive prenatal testing.
The couple reflects on the value of NIPT and its ability to provide couples like them with more accurate answers.
Embryologists from all over the world gathered for the Global Embryology Summit, an exclusive event featuring hands-on instructor-led workshops designed by fellow embryologists to improve best practices…
Join Angie Beltsos, MD, as she explores the latest advancements in fertility. Topics include minimizing risk of hyperstimulation, optimizing health of the transferred embryo, and improving the odds…
Dr. Robert Anderson, Director of the Southern California Center for Reproductive Medicine and Medical Director for the Southern California Institute for Reproductive Sciences, discusses how preimplantation…
Childhood sweethearts, now husband and wife, Vy and Kyle share their personal in vitro fertilization success story. You ll hear how Illumina preimplantation genetic screening (PGS) helped them fulfill…
Innovative BlueFuse Multi Software
Learn how the NextSeq 550 is enhancing research in reproductive and genetic health and why it’s being rapidly adopted in genetic testing labs. Get a glimpse into the advantages of this integrated, cost-effective solution for diverse applications.
Professor Yuval Yaron discusses the implications of test failures.
Maternal fetal medicine specialist Dr. Tracy Prosen highlights the differences between screening and diagnostic prenatal tests.
Yang et al reported a 65% increase in pregnancy at 20 weeks, with a 69.1% pregnancy rate after 24sure selection of euploid embryos (n = 55) versus 41.7% after standard morphological selection of embryos (n = 48).
Learn how Illumina technologies are used for PGS, PGD, NIPT, and research on genetic conditions in our Reproductive and Genetic Health issue.
Learn about the 2011-2012 Society for Assisted Reproductive Technology (SART) data analysis of pregnancy outcomes in IVF cycles with and without PGS as reported to the Centers for Disease Control (CDC).
Noninvasive prenatal testing in the general obstetric population.
Prenatal testing with the use of cfDNA has significantly lower false positive rates and higher positive predictive values for detection of trisomies 21 and 18 than standard screening.
"Illumina is committed to supporting independent medical education for women's healthcare providers. Click above to participate in a free CME activity about ""The Role of Noninvasive Prenatal Screening in Optimizing Fetal Outcomes"". "
Read the blog post on positive predictive value and download the publication
Discover the use of arrays to investigate individuals with intellectual disability, developmental delay, autism, and congenital abnormalities.
To learn more about the benefits of an expanded CF screen, read “Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene.” by PR Sosnay, et al.
Read how PGS and PGD can improve IVF outcomes through better embryo selection.
Learn how the application of NGS in clinical PGS cycles allows for identification and transfer of euploid embryos resulting in ongoing pregnancies.
Share this brochure with your patients to educate them about PGD.
Learn how karyomapping offers a rapid PGD solution for single-gene disorders.
For tips about how to choose the best sequencer and transform your lab, download the Buyer's Guide to Next-Generation Sequencing Systems.
Learn how PGS and PGD solutions can produce accurate genomic information for optimized embryo selection and more informed decisions about reproductive options.
A brief, educational primer about next-generation sequencing for in vitro fertilization.
Share this brochure with your patients to educate them about PGS and how it can improve IVF success rates.
A poster presentation from the 2015 Annual Meeting of the Society for Maternal- Fetal Medicine.
Dr. Leeanda Wilton of Melbourne IVF codeveloped genomic methods that were key predecessors of technologies that are now contributing to successful IVF pregnancies.
Dr. Don Leigh and his team at Genea are harnessing the speed and accuracy of the VeriSeq PGS Solution on the MiSeq System to assess the genetic viability of embryos.
New technologies and procedures help tackle infertility.
Data shows Illumina next-generation sequencing is the NIPT technology of choice.
Download the handout on the Importance of Carrier Screening
View all 174 genes, related to 17 ICCs, detected by the TruSight Cardio Sequencing Kit.
Drs. Koehler and Benet-Pages are using the Infinium CytoSNP-850K BeadChip and the TruSight Cancer Panel to analyze chromosomal abnormalities.
Trilochan Sahoo, MD discusses the benefits of the CytoSNP-850K BeadChip array.
Visual aids for patient discussions about reproductive genetic concepts such as PGS and NIPT.
Learn more about the MiSeqDx Cystic Fibrosis System.
See vital statistics around sudden cardiac arrest, one of the leading causes of non-traumatic fatality in the US.
An introduction to NGS technology and applications for labs.
Noninvasive prenatal screening (NIPT) was found cost-effective as first line screening for all pregnant women.
Viafet enables IVF clinics throughout the Middle East and Australia to provide fast, accurate, and efficient PGS services.
Study published in NEJM finds Verifi Prenatal Test achieves 10×higher positive predictive value vs. current standard of care.
Download this guide for healthcare professionals on NIPT and the benefits of the Verifi prenatal test.
Whole-genome noninvasive prenatal testing provides results when another test was inconclusive.
Learn more about the Verifi Prenatal Test—a reliable, easy, fast, noninvasive prenatal test.
Learn how Dr Kenjiro Kosaki furthers his clinical research and expands the genetic analysis services he provides with TruSight One Sequencing Panel.
Whole-genome sequencing can potentially broaden and foreshorten differential diagnosis, resulting in fewer empirical treatments and faster progression to genetic and prognostic counseling.
Learn how Dr Stephen Kingsmore aided in decoding the genomes of children being seen at Children’s Mercy Hospital.
Hear from Dr Heidi Rehm and learn how she is identifying the causal variants of cardiomyopathy.
Simon Fishel describes how the highly-accurate VeriSeq PGS Kit empowers clinicians with accurate chromosomal insights into the health of the embryo to optimize IVF success.
Learn about a randomized controlled trial comparing pregnancy rates following VeriSeq PGS versus standard morphology for elective single embryo transfer.
Dr. Glenn Palomaki shares his data and expert opinion on the clinical utility of NIPT in the general pregnancy population.
Learn how the Verifi Prenatal Test uses proven NGS technology to provide accurate NIPT results.
Discovering rare chromosomal abnormalities using WGS-based NIPT.
Hear a firsthand testimonial of how Illumina PGS technology made a difference for one family.
Martin Chavez, MD, a maternal-fetal medicine specialist, discusses noninvasive prenatal testing.
Dr. Chavez discusses the benefits of NIPT for prenatal screening of fetal chromosomal aneuploidies.
Noninvasive prenatal screening (NIPT) was found cost-effective as first line screening for all pregnant women.
An overview of recent publications featuring Illumina solutions for preimplantation genetics technology.
Learn about our partnerships with professional societies and organizations—striving together to advance awareness of genetics and health.